RJ Founded in 1929 in Spain, Reig Jofre is a leading industrial group in the European pharmaceutical market. Family owned, it has more than 600 employees and strong growth over the last years.
The structure includes four divisions:
Industrial Services Division
The group is a leader in providing manufacturing services and out-licensing dossiers of specialised products....This activity is complemented with production services for third parties, specialising in sterile products for injection, freeze-dried products (with a dedicated center of excellence), and penicillin / cephalosporin antibiotics, as well as advanced topical formulations.
Pharma Division
RJ sells its own products in the Spanish market under the brands Reig Jofre, Medea, Orravan and Sala; and in the Nordics, under the brand Bioglan. Reig Jofre Group specialises in the fields of Dermatology, Women's Care, Respiratory, Anti-infectious, Pediatrics and Retail Consumer Healthcare products. In addition RJ is a key player in Spain and United Kingdom in the hospital sector, offering a wide range of injectable products.
R&D and Regulatory Division
The scientific division is dedicated to identifying and developing projects that are relevant for International markets. From improved formulation to new indications for existing molecules, as well as specialiced generics and molecular diagnostics. RJ has a wide experience in Decentralized and Mutual Recognition Procedures in Europe, as well as preparing FDA compliant Dossiers.
RJ Biotech Services
A multidisciplinary team with broad experience in the development of biological products, working closely with scientific knowledge, and translating the initial development into a robust and scalable process. RJ Biotech Services provides high quality development/optimization and GMP bioproduction services, with a special focus on injectableforms. We offer a wide range of services that cover the entire development chain (including analytical development, process development, quality control, quality assurance, stability studies and regulatory requirements).

Pharmalink is a Spanish company that focuses on the manufacture of medical devices, food supplements and cosmetics.
Pharmalink is the result of the long experience of its professional team in the pharmaceutical, cosmetic and related industries.
It has a production plant of 5.000m2 equipped with modern technology and fully automated machines. ...
Pharmalink aims to provide comprehensive and flexible solutions to customers, controlling the entire value chain of the product, from design to logistics.
Pharmalink is offering to its customers products with high added value without any other intermediary.

Bioplax Ltd. is a young R&D company that specialises in oral care.
The first line of products manufactured by the company is currently marketed under the trademark Aftamed®. It is also sold in some countries under the name of Bloxaphte®, Gum Aftamed®, Aftex®, Aftaspray® or Aftum®....
The company's strong points are its international patents, health registrations in various countries, and clinical and scientific evidence (ie. the quality, safety and efficacy of its products).

Pharmathen Pharmaceuticals is a private pharmaceutical company focused on developing and marketing of health care products, with a strong position in generics.
Headquarters in Athens, Greece
Founded in 1969 by Nicolaos Katsos, it is one of the fastest growing pharmaceutical companies in Greece.
With 3 ultra-modern research laboratories and 2 industrial units....
The company’s workforce is made up of more than 650 employees working in the fields of Research & Development (R&D), production, and promotion of pharmaceutical products for more than 85 countries worldwide.
Today Pharmathen’s products are approved in all EU countries and their distribution rights are granted to the biggest pharmaceutical companies in the world, particularly in Europe, the United States of America and Canada.
Pharmathen’s sales amounted to €115 million in 2009; it ranks as the number 1 company in Greece in terms of revenues.

Ordesa is a Spanish company that has been specializing in baby nutrition products for over 65 years.
Over the course of all these years the company had been committed to quality, innovation and satisfaction, all of which has led it to become well-known in Europe, the Middle East, Latin America and North Africa....
AUG has in place an agreement with Ordesa to acquire a private label of Ordesa’s Cereal products under the brand name of AUG, in addition to the packaging, distribution, and marketing activities related to the product in Egypt.

Rontis is a Switzerland based Multinational Corporation. It was established in 1986 by a group of leading professionals with lengthy experience in the wider healthcare sector and a vision to provide the most innovative & trustworthy solutions in the market, aiming to become an international leader in the global healthcare industry.
Rontis specializes in the fields of Medical Devices, Pharmaceuticals, Healthcare Services, Infant and Baby Nutrition, and Consumer Healthcare....
AUG Pharma is having a partnership with renowned Rontis. The partnership gives AUG Pharma the privilege of executing marketing and distribution activities for Rontis’ infant milk Rontamil. Rontamil is the optimum choice, given the fact that it reinforces the immune system of the infant, it reduces the diarrhea incidents and it prevents allergies.
Rontis is focusing on developing specialized types of infant formulas destined to treat certain gastrointestinal disorders such as infantile colics, constipation and regurgitation, that infants and babies can develop in the first years of their lives and that is what Rontamil’s unique formula is for, treating these disorders through nutrition.

The Cigalah Group head quartered in Jeddah is made up several companies and divisions covering a diversified range of activities which include:
- Consumer Products (FMCG)
- Pharmaceuticals & Healthcare
- Watch, Textile & Retail
- Food Production and Packaging
Cigalah was established in the late 1980's initially as marketing,... sales and distribution company, whose overall philosophy put simply was "To Put the Right Products on Shelves...in the Best Possible Light, and with the Best Marketing Support, so that Consumers Would Buy Them"
This basic philosophy remains the same and has been the foundation of the group's success. But since that time Cigalah has recognised the development of the markets in terms of requirements for products and services. Accordingly has grown and expanded into several diversified sectors from consumerable and non-consumerable retail products to healthcare (products and services) and manufacturing. This has resulted in Cigalah being now a fully structured group of self sufficient companies and divisions.